UroGen Pharma financial statements

우로젠 파머NASDAQ:URGN · Nasdaq · Healthcare · sector #17
$41.43-3.16%
2026-10-06 close

UroGen Pharma's published financial data is dated 2026-10-04. 2024 revenue was $90M. 2024 operating profit was −$97M.

Reported results

UroGen Pharma notifications

Quantus Signal · live data · not investment advice · Privacy Policy